Helmerich & Payne (HP) Financials

$19.72 +0.49 (+2.54%)

Closing price 03:59 PM Eastern

Extended Trading

$19.72 +0.00 (+0.01%)

As of 06:00 PM Eastern

Annual Income Statements for Helmerich & Payne

This table shows Helmerich & Payne's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	420	-57	-128	483	-34	-494	-326	6.95	434	344
Consolidated Net Income / (Loss)	420	-57	-128	483	-34	-494	-326	6.95	434	344
Net Income / (Loss) Continuing Operations	420	-53	-128	493	-33	-496	-326	6.95	434	344
Total Pre-Tax Income	662	-73	-185	16	-51	-636	-430	31	593	481
Total Operating Income	672	-26	-169	33	21	-620	-429	45	562	452
Total Gross Profit	1,458	725	555	835	995	583	261	628	1,153	1,122
Total Revenue	3,162	1,624	1,805	2,487	2,798	1,774	1,219	2,059	2,872	2,757
Operating Revenue	3,162	1,624	1,805	2,487	2,798	1,774	1,219	2,059	2,872	2,757
Total Cost of Revenue	1,703	899	1,249	1,653	1,803	1,191	958	1,431	1,720	1,635
Operating Cost of Revenue	1,703	893	1,245	1,648	1,803	1,185	953	1,427	1,715	1,630
Other Cost of Revenue	-	6.06	4.58	5.05	-	5.78	5.14	4.64	4.48	4.48
Total Operating Expenses	786	751	725	802	975	1,204	689	582	591	670
Selling, General & Admin Expense	135	146	148	199	194	168	172	182	207	245
Research & Development Expense	16	10	12	18	27	22	22	27	30	41
Depreciation Expense	608	599	586	584	563	482	420	403	382	397
Other Operating Expenses / (Income)	-	-	-	-	5.38	-27	-12	-29	-48	-33
Impairment Charge	39	6.25	0.00	23	224	563	71	4.36	12	0.00
Restructuring Charge	-	-	-	0.00	0.00	16	5.93	0.84	0.00	15
Other Special Charges / (Income)	-12	-9.90	-21	-23	-40	-20	11	-5.43	8.02	5.14
Total Other Income / (Expense), net	-10	-47	-16	-17	-72	-16	-1.32	-14	31	29
Interest Expense	15	23	20	24	25	24	24	79	17	29
Interest & Investment Income	5.84	-23	5.92	8.02	-45	14	17	76	40	55
Other Income / (Expense), net	-0.90	-0.97	-1.68	-0.88	-1.60	-5.38	5.65	-11	9.08	3.09
Income Tax Expense	241	-20	-57	-477	-19	-140	-104	24	159	137
Basic Earnings per Share	$3.88	($0.54)	($1.20)	$4.39	($0.34)	($4.60)	($3.04)	$0.05	$4.18	$3.43
Weighted Average Basic Shares Outstanding	107.75M	108.00M	108.50M	108.85M	109.22M	108.01M	107.82M	105.89M	102.45M	98.86M
Diluted Earnings per Share	$3.85	($0.54)	($1.20)	$4.37	($0.34)	($4.60)	($3.04)	$0.05	$4.16	$3.43
Weighted Average Diluted Shares Outstanding	108.57M	108.00M	108.50M	109.39M	109.22M	108.01M	107.82M	106.56M	102.85M	99.07M
Weighted Average Basic & Diluted Shares Outstanding	108.40M	105.20M	106.80M	109.90M	108.45M	107.60M	108.00M	105.39M	99.43M	98.76M
Cash Dividends to Common per Share	$2.75	$2.78	$2.80	$2.82	$2.84	$1.92	$1.00	$1.00	$1.00	$0.25

This table shows Helmerich & Payne's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Net Income / (Loss) Attributable to Common Shareholders	18	46	97	164	95	78	95	85	89	75	55
Consolidated Net Income / (Loss)	18	46	97	164	95	78	95	85	89	75	55
Net Income / (Loss) Continuing Operations	17	45	97	164	95	78	95	85	89	75	55
Total Pre-Tax Income	19	73	130	215	136	113	125	117	122	116	76
Total Operating Income	34	77	144	175	149	94	123	111	111	107	90
Total Gross Profit	173	219	290	319	294	250	273	285	280	285	264
Total Revenue	550	631	720	769	724	660	677	688	698	694	677
Operating Revenue	550	631	720	769	724	660	677	688	698	694	677
Total Cost of Revenue	377	412	429	450	430	410	404	403	418	409	413
Operating Cost of Revenue	376	411	428	449	429	409	403	402	417	408	412
Other Cost of Revenue	1.05	1.22	1.13	1.19	1.00	1.16	1.14	1.03	1.14	1.18	1.16
Total Operating Expenses	139	142	146	144	145	156	149	174	168	178	174
Selling, General & Admin Expense	45	47	48	53	49	56	57	62	67	59	63
Research & Development Expense	6.51	7.14	6.93	8.70	7.09	7.33	8.61	13	11	8.86	9.36
Depreciation Expense	101	99	97	96	95	95	94	105	98	101	99
Other Operating Expenses / (Income)	-9.90	-7.85	-16	-12	-11	-10	-7.49	-7.46	-9.73	-8.62	-9.40
Restructuring Charge	0.03	-	-	-	-	-	0.00	-	-	-	11
Other Special Charges / (Income)	-3.08	-2.67	-2.38	-2.52	4.50	8.41	-2.44	2.43	2.73	2.42	1.67
Total Other Income / (Expense), net	-15	-3.83	-15	40	-13	19	1.79	6.45	11	9.81	-14
Interest Expense	4.37	4.33	4.36	4.24	4.32	4.37	4.37	4.26	4.34	16	22
Interest & Investment Income	-9.00	9.04	-10	45	-7.79	13	6.70	10	12	26	8.37
Other Income / (Expense), net	-1.15	-8.55	0.06	-0.60	-0.67	10	-0.54	0.40	3.13	0.10	0.36
Income Tax Expense	1.73	28	32	51	41	35	30	32	34	41	22
Basic Earnings per Share	$0.16	$0.42	$0.92	$1.55	$0.93	$0.78	$0.95	$0.85	$0.89	$0.74	$0.55
Weighted Average Basic Shares Outstanding	105.29M	105.89M	105.25M	103.97M	101.16M	102.45M	99.14M	98.77M	98.75M	98.86M	98.87M
Diluted Earnings per Share	$0.16	$0.42	$0.91	$1.55	$0.93	$0.77	$0.94	$0.84	$0.88	$0.77	$0.54
Weighted Average Diluted Shares Outstanding	106.02M	106.56M	106.10M	104.36M	101.55M	102.85M	99.63M	99.05M	99.01M	99.07M	99.16M
Weighted Average Basic & Diluted Shares Outstanding	105.29M	105.39M	104.49M	102.58M	99.43M	99.43M	98.83M	98.72M	98.76M	98.76M	99.38M
Cash Dividends to Common per Share	$0.25	-	$0.25	$0.25	$0.25	-	$0.17	$0.25	$0.25	-	$0.25

This table details how cash moves in and out of Helmerich & Payne's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	369	176	-375	-234	57	154	400	-668	47	1,212
Net Cash From Operating Activities	1,429	755	371	558	856	539	136	234	834	685
Net Cash From Continuing Operating Activities	1,429	754	371	558	856	539	136	234	834	685
Net Income / (Loss) Continuing Operations	420	-53	-128	493	-33	-496	-326	6.95	434	344
Consolidated Net Income / (Loss)	420	-57	-128	483	-34	-494	-326	6.95	434	344
Depreciation Expense	608	599	586	584	563	482	420	403	382	397
Amortization Expense	0.75	1.17	1.06	1.07	1.73	1.82	1.42	1.20	1.08	11
Non-Cash Adjustments To Reconcile Net Income	61	50	9.76	42	280	546	94	6.81	2.08	-5.79
Changes in Operating Assets and Liabilities, net	338	158	-97	-562	44	5.29	-52	-184	14	-62
Net Cash From Investing Activities	-1,154	-234	-445	-472	-423	-88	-162	-167	-323	-459
Net Cash From Continuing Investing Activities	-1,154	-234	-445	-472	-423	-88	-162	-167	-323	-459
Purchase of Property, Plant & Equipment	-1,131	-257	-398	-467	-458	-141	-82	-273	-395	-495
Purchase of Investments	-46	-57	-70	-71	-98	-135	-418	-216	-202	-210
Sale of Property, Plant & Equipment	23	22	23	44	51	78	130	62	70	46
Sale and/or Maturity of Investments	0.00	58	69	69	99	95	208	267	195	204
Other Investing Activities, net	-	-	-	0.00	0.00	0.00	0.00	-7.50	9.22	-4.47
Net Cash From Financing Activities	95	-344	-301	-320	-376	-297	426	-734	-464	987
Net Cash From Continuing Financing Activities	95	-344	-301	-320	-376	-297	426	-734	-464	987
Repayment of Debt	-46	-41	0.00	0.00	-17	-0.45	-4.65	-488	-0.54	-23
Repurchase of Common Equity	-60	-	0.00	0.00	-43	-29	0.00	-77	-247	-51
Payment of Dividends	-298	-300	-306	-308	-313	-260	-109	-107	-201	-168
Issuance of Debt	498	-	-	-	0.00	0.00	549	0.00	0.00	1,248
Other Financing Activities, net	1.28	-2.87	4.69	-11	-3.37	-7.93	-9.41	-62	-15	-18
Cash Interest Paid	-	28	23	21	27	23	27	19	17	16
Cash Income Taxes Paid	-	-24	-23	-38	16	47	1.46	18	199	181

This table details how cash moves in and out of Helmerich & Payne's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Net Change in Cash & Equivalents	-6.79	46	2.65	-59	69	34	-37	-17	20	1,247	178
Net Cash From Operating Activities	98	117	185	141	293	215	175	144	197	169	158
Net Cash From Continuing Operating Activities	98	117	185	141	293	215	175	144	197	169	158
Net Income / (Loss) Continuing Operations	17	45	97	164	95	78	95	85	89	75	55
Consolidated Net Income / (Loss)	18	46	97	164	95	78	95	85	89	75	55
Depreciation Expense	101	99	97	96	95	95	94	105	98	101	99
Amortization Expense	0.32	0.32	-	-	-	-	0.15	-	-	-	2.39
Non-Cash Adjustments To Reconcile Net Income	10	2.93	28	-52	22	4.43	2.07	0.92	1.36	-10	12
Changes in Operating Assets and Liabilities, net	-31	-31	-36	-67	81	37	-17	-47	9.53	-7.98	-9.99
Net Cash From Investing Activities	-78	-44	-82	-37	-72	-132	-113	-111	-130	-105	53
Net Cash From Continuing Investing Activities	-78	-44	-82	-37	-72	-132	-113	-111	-130	-105	53
Purchase of Property, Plant & Equipment	-78	-79	-96	-85	-100	-114	-136	-118	-134	-106	-106
Purchase of Investments	-74	-60	-58	-25	-38	-81	-47	-36	-75	-52	-97
Sale of Property, Plant & Equipment	15	12	31	17	15	7.04	12	8.97	14	11	12
Sale and/or Maturity of Investments	66	83	41	57	51	47	58	29	65	52	243
Other Investing Activities, net	-	-	-	-	-	9.22	0.00	-	0.55	-10	0.70
Net Cash From Financing Activities	-27	-27	-101	-163	-152	-49	-99	-49	-48	1,183	-33
Net Cash From Continuing Financing Activities	-27	-27	-101	-163	-152	-49	-99	-49	-48	1,183	-33
Repayment of Debt	-	-	-	-	0.25	-	0.00	-	0.25	-23	-1.22
Repurchase of Common Equity	-	-	-39	-106	-102	-	-47	-3.94	-	-	0.00
Payment of Dividends	-27	-27	-52	-51	-50	-49	-42	-42	-42	-42	-25
Other Financing Activities, net	-0.01	0.01	-9.73	-4.68	-0.25	-	-9.07	-3.11	-6.25	-0.00	-6.91
Cash Interest Paid	0.09	8.02	0.92	8.00	0.04	8.14	0.93	7.12	0.10	7.80	0.00
Cash Income Taxes Paid	2.76	14	3.74	114	38	43	5.96	75	58	42	4.28

This table presents Helmerich & Payne's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	7,147	6,832	6,440	6,215	5,840	4,830	5,034	4,356	4,382	5,782
Total Current Assets	1,439	1,573	1,235	1,116	1,115	963	1,587	1,003	1,007	1,192
Cash & Equivalents	729	906	521	284	348	488	918	232	257	217
Restricted Cash	-	-	-	-	-	-	18	36	59	69
Short-Term Investments	46	44	44	41	53	89	199	117	94	293
Accounts Receivable	446	375	477	565	496	193	229	459	404	419
Inventories, net	129	124	137	158	150	104	84	88	94	118
Prepaid Expenses	64	78	55	66	69	89	68	66	98	76
Plant, Property, & Equipment, net	5,563	5,145	5,001	4,857	4,502	3,646	3,127	2,961	2,922	3,016
Total Noncurrent Assets	145	115	204	242	222	220	320	392	454	1,574
Long-Term Investments	104	85	84	99	32	32	135	219	265	101
Goodwill	-	4.72	52	65	83	46	46	46	46	46
Intangible Assets	-	0.92	51	73	87	81	74	67	61	54
Other Noncurrent Operating Assets	41	24	17	5.26	21	62	65	60	82	1,373
Total Liabilities & Shareholders' Equity	7,147	6,832	6,440	6,215	5,840	4,830	5,034	4,356	4,382	5,782
Total Liabilities	2,251	2,271	2,271	1,832	1,827	1,511	2,122	1,590	1,610	2,865
Total Current Liabilities	348	330	344	377	410	219	866	395	419	447
Accounts Payable	108	95	136	133	45	36	72	127	131	135
Accrued Expenses	198	235	209	245	287	155	283	241	263	287
Dividends Payable	-	-	-	-	78	27	27	27	25	25
Total Noncurrent Liabilities	1,903	1,941	1,927	1,455	1,417	1,292	1,255	1,195	1,191	2,418
Long-Term Debt	492	492	493	494	479	481	542	543	545	1,782
Noncurrent Deferred & Payable Income Tax Liabilities	1,296	1,342	1,333	853	807	651	563	538	518	495
Other Noncurrent Operating Liabilities	110	103	101	94	116	147	148	115	128	140
Commitments & Contingencies	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	4,896	4,561	4,165	4,383	4,012	3,319	2,913	2,765	2,772	2,917
Total Preferred & Common Equity	4,896	4,561	4,165	4,383	4,012	3,319	2,913	2,765	2,772	2,917
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	4,896	4,561	4,165	4,383	4,012	3,319	2,913	2,765	2,772	2,917
Common Stock	431	460	498	512	522	533	541	540	537	529
Retained Earnings	4,648	4,290	3,856	4,028	3,714	3,010	2,573	2,474	2,708	2,884
Treasury Stock	-182	-188	-192	-173	-195	-198	-182	-236	-464	-489
Accumulated Other Comprehensive Income / (Loss)	-1.38	-0.20	2.30	17	-29	-26	-20	-12	-7.98	-6.35

This table presents Helmerich & Payne's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Total Assets	4,323	4,412	4,366	4,341	4,421	4,425	4,485	5,817
Total Current Assets	946	1,079	1,004	993	989	949	970	1,225
Cash & Equivalents	189	229	160	221	214	194	204	391
Restricted Cash	-	42	53	61	65	69	78	73
Short-Term Investments	144	118	85	73	84	83	86	135
Accounts Receivable	398	513	526	450	436	432	415	427
Inventories, net	86	91	99	101	101	107	115	127
Prepaid Expenses	104	84	80	86	88	64	72	71
Plant, Property, & Equipment, net	2,987	2,942	2,931	2,933	2,970	2,994	3,014	3,009
Total Noncurrent Assets	389	391	430	415	462	482	500	1,582
Long-Term Investments	214	221	262	246	263	274	292	102
Goodwill	46	46	46	46	46	46	46	46
Intangible Assets	69	65	64	62	59	57	56	53
Other Noncurrent Operating Assets	61	59	59	62	94	105	107	1,383
Total Liabilities & Shareholders' Equity	4,323	4,412	4,366	4,341	4,421	4,425	4,485	5,817
Total Liabilities	1,590	1,667	1,610	1,633	1,662	1,622	1,628	2,870
Total Current Liabilities	401	470	414	433	469	439	457	436
Accounts Payable	120	146	160	152	157	158	159	149
Accrued Expenses	255	272	203	233	270	238	256	262
Dividends Payable	27	52	50	49	42	42	42	25
Total Noncurrent Liabilities	1,189	1,197	1,196	1,199	1,193	1,183	1,171	2,434
Long-Term Debt	542	543	543	545	545	545	546	1,782
Noncurrent Deferred & Payable Income Tax Liabilities	528	537	540	541	510	502	494	486
Other Noncurrent Operating Liabilities	117	116	113	113	137	135	131	167
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,733	2,745	2,756	2,708	2,760	2,803	2,857	2,947
Total Preferred & Common Equity	2,733	2,745	2,756	2,708	2,760	2,803	2,857	2,947
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,733	2,745	2,756	2,708	2,760	2,803	2,857	2,947
Common Stock	533	524	520	528	518	514	522	513
Retained Earnings	2,455	2,494	2,608	2,655	2,744	2,786	2,833	2,913
Treasury Stock	-236	-261	-361	-464	-494	-490	-489	-473
Accumulated Other Comprehensive Income / (Loss)	-19	-12	-12	-11	-7.85	-7.71	-8.50	-5.99

This table displays calculated financial ratios and metrics derived from Helmerich & Payne's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-14.92%	-48.63%	11.11%	37.82%	12.51%	-36.61%	-31.31%	68.96%	39.51%	-4.03%
EBITDA Growth	-18.82%	-55.24%	-27.41%	48.37%	-5.42%	-124.31%	98.77%	25,211.44%	117.42%	-9.58%
EBIT Growth	-36.24%	-104.01%	-534.09%	118.79%	-40.83%	-3,394.91%	32.40%	108.18%	1,551.25%	-20.31%
NOPAT Growth	-37.21%	-104.26%	-551.19%	966.77%	-98.60%	-3,113.25%	30.90%	103.35%	3,988.11%	-21.34%
Net Income Growth	-40.50%	-113.52%	-125.61%	476.46%	-106.97%	-1,369.27%	34.04%	102.13%	6,143.35%	-20.72%
EPS Growth	-40.22%	-114.03%	-122.22%	464.17%	-107.78%	-1,252.94%	33.91%	101.64%	8,220.00%	-17.55%
Operating Cash Flow Growth	26.53%	-47.18%	-50.80%	50.28%	53.40%	-37.03%	-74.68%	71.44%	256.41%	-17.87%
Free Cash Flow Firm Growth	38.12%	102.09%	-121.26%	628.88%	-42.38%	47.88%	-51.98%	-109.78%	2,174.53%	-322.38%
Invested Capital Growth	4.01%	-11.57%	-0.26%	11.34%	-7.04%	-22.18%	-16.52%	1.22%	-2.30%	51.63%
Revenue Q/Q Growth	-11.91%	-12.03%	12.50%	7.08%	-1.68%	-19.90%	12.51%	16.23%	0.99%	1.26%
EBITDA Q/Q Growth	-17.02%	-10.53%	12.12%	8.27%	0.03%	-15,593.47%	-110.18%	53.83%	3.51%	2.32%
EBIT Q/Q Growth	-29.96%	-163.83%	28.28%	272.23%	414.94%	-22.66%	-2.73%	128.34%	6.68%	0.58%
NOPAT Q/Q Growth	-30.94%	-31.34%	28.31%	8,488.27%	256.46%	-22.63%	-5.31%	111.17%	3.90%	1.51%
Net Income Q/Q Growth	-31.59%	-390.36%	28.18%	5.46%	53.50%	-25.39%	-6.60%	105.91%	7.98%	-0.62%
EPS Q/Q Growth	-31.37%	-390.91%	28.14%	5.56%	50.00%	-25.00%	-5.92%	104.55%	9.19%	0.00%
Operating Cash Flow Q/Q Growth	-3.65%	-15.45%	-2.16%	11.04%	1.18%	-16.14%	-25.22%	43.28%	13.23%	-6.29%
Free Cash Flow Firm Q/Q Growth	78.62%	8.76%	-170.06%	223.24%	-2.89%	16.65%	21.35%	-129.59%	5.06%	-547.14%
Invested Capital Q/Q Growth	-2.45%	-3.81%	-1.10%	-0.91%	-0.50%	-5.01%	-7.75%	-0.96%	-1.25%	45.27%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	46.12%	44.66%	30.78%	33.56%	35.57%	32.89%	21.40%	30.49%	40.14%	40.70%
EBITDA Margin	40.48%	35.27%	23.04%	24.80%	20.85%	-8.00%	-0.14%	21.32%	33.23%	31.30%
Operating Margin	21.25%	-1.60%	-9.37%	1.33%	0.74%	-34.96%	-35.17%	2.20%	19.56%	16.39%
EBIT Margin	21.22%	-1.66%	-9.46%	1.29%	0.68%	-35.26%	-34.70%	1.68%	19.88%	16.51%
Profit (Net Income) Margin	13.30%	-3.50%	-7.10%	19.41%	-1.20%	-27.88%	-26.77%	0.34%	15.11%	12.49%
Tax Burden Percent	63.52%	78.20%	69.45%	3,046.98%	65.71%	77.69%	75.87%	22.20%	73.16%	71.55%
Interest Burden Percent	98.63%	269.83%	108.10%	49.37%	-269.79%	101.75%	101.65%	90.57%	103.92%	105.72%
Effective Tax Rate	36.47%	0.00%	0.00%	-3,012.24%	0.00%	0.00%	0.00%	77.80%	26.84%	28.45%
Return on Invested Capital (ROIC)	9.57%	-0.42%	-2.95%	24.20%	0.33%	-11.76%	-10.12%	0.37%	15.23%	9.63%
ROIC Less NNEP Spread (ROIC-NNEP)	11.06%	8.29%	-0.10%	1,592.74%	-42.72%	-243.47%	7.17%	2.85%	-17.77%	13.71%
Return on Net Nonoperating Assets (RNNOA)	-0.98%	-0.78%	0.01%	-12.91%	-1.14%	-1.73%	-0.35%	-0.13%	0.45%	2.46%
Return on Equity (ROE)	8.59%	-1.20%	-2.94%	11.29%	-0.80%	-13.49%	-10.47%	0.24%	15.68%	12.10%
Cash Return on Invested Capital (CROIC)	5.64%	11.85%	-2.69%	13.47%	7.64%	13.18%	7.88%	-0.84%	17.56%	-31.40%
Operating Return on Assets (OROA)	9.68%	-0.39%	-2.57%	0.51%	0.32%	-11.73%	-8.57%	0.74%	13.07%	8.95%
Return on Assets (ROA)	6.06%	-0.81%	-1.93%	7.63%	-0.56%	-9.27%	-6.61%	0.15%	9.94%	6.77%
Return on Common Equity (ROCE)	8.59%	-1.20%	-2.94%	11.29%	-0.80%	-13.49%	-10.47%	0.24%	15.68%	12.10%
Return on Equity Simple (ROE_SIMPLE)	8.59%	-1.25%	-3.08%	11.01%	-0.84%	-14.90%	-11.20%	0.25%	15.66%	11.80%
Net Operating Profit after Tax (NOPAT)	427	-18	-118	1,026	14	-434	-300	10	411	323
NOPAT Margin	13.50%	-1.12%	-6.56%	41.25%	0.51%	-24.47%	-24.62%	0.49%	14.31%	11.73%
Net Nonoperating Expense Percent (NNEP)	-1.49%	-8.72%	-2.85%	-1,568.54%	43.05%	231.71%	-17.29%	-2.48%	33.00%	-4.07%
Cost of Revenue to Revenue	53.88%	55.34%	69.22%	66.44%	64.43%	67.11%	78.60%	69.51%	59.87%	59.30%
SG&A Expenses to Revenue	4.26%	9.00%	8.18%	8.01%	6.95%	9.44%	14.13%	8.86%	7.19%	8.88%
R&D to Revenue	0.51%	0.63%	0.67%	0.73%	0.98%	1.22%	1.78%	1.29%	1.05%	1.49%
Operating Expenses to Revenue	24.87%	46.26%	40.14%	32.23%	34.83%	67.85%	56.57%	28.29%	20.57%	24.31%
Earnings before Interest and Taxes (EBIT)	671	-27	-171	32	19	-626	-423	35	571	455
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,280	573	416	617	584	-142	-1.75	439	954	863
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.66	1.07	0.96	1.26	0.85	0.40	0.90	1.28	1.44	1.03
Price to Tangible Book Value (P/TBV)	0.66	1.07	0.98	1.30	0.88	0.42	0.94	1.34	1.50	1.07
Price to Revenue (P/Rev)	1.03	3.00	2.21	2.21	1.21	0.75	2.15	1.72	1.39	1.09
Price to Earnings (P/E)	7.73	0.00	0.00	11.41	0.00	0.00	0.00	510.12	9.23	8.73
Dividend Yield	9.12%	6.13%	7.64%	5.56%	9.16%	19.14%	4.12%	2.97%	2.48%	4.14%
Earnings Yield	12.94%	0.00%	0.00%	8.76%	0.00%	0.00%	0.00%	0.20%	10.84%	11.46%
Enterprise Value to Invested Capital (EV/IC)	0.64	1.08	0.95	1.25	0.83	0.37	0.88	1.28	1.45	1.02
Enterprise Value to Revenue (EV/Rev)	0.92	2.67	2.12	2.24	1.23	0.68	1.95	1.69	1.35	1.49
Enterprise Value to EBITDA (EV/EBITDA)	2.27	7.56	9.19	9.04	5.90	0.00	0.00	7.94	4.06	4.76
Enterprise Value to EBIT (EV/EBIT)	4.32	0.00	0.00	173.78	181.25	0.00	0.00	100.79	6.79	9.03
Enterprise Value to NOPAT (EV/NOPAT)	6.79	0.00	0.00	5.44	238.85	0.00	0.00	346.59	9.43	12.70
Enterprise Value to Operating Cash Flow (EV/OCF)	2.03	5.74	10.30	10.00	4.02	2.24	17.39	14.90	4.65	6.00
Enterprise Value to Free Cash Flow (EV/FCFF)	11.54	8.52	0.00	9.76	10.46	2.48	10.15	0.00	8.18	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.11	0.11	0.12	0.11	0.12	0.14	0.35	0.20	0.20	0.61
Long-Term Debt to Equity	0.10	0.11	0.12	0.11	0.12	0.14	0.19	0.20	0.20	0.61
Financial Leverage	-0.09	-0.09	-0.08	-0.01	0.03	0.01	-0.05	-0.04	-0.03	0.18
Leverage Ratio	1.42	1.48	1.52	1.48	1.44	1.46	1.58	1.65	1.58	1.79
Compound Leverage Factor	1.40	3.99	1.64	0.73	-3.87	1.48	1.61	1.50	1.64	1.89
Debt to Total Capital	9.79%	9.73%	10.58%	10.13%	10.67%	12.65%	26.04%	16.40%	16.43%	37.92%
Short-Term Debt to Total Capital	0.72%	0.00%	0.00%	0.00%	0.00%	0.00%	12.28%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	9.07%	9.73%	10.58%	10.13%	10.67%	12.65%	13.76%	16.40%	16.43%	37.92%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	90.21%	90.27%	89.42%	89.87%	89.33%	87.35%	73.96%	83.60%	83.57%	62.08%
Debt to EBITDA	0.42	0.86	1.19	0.80	0.82	-3.39	-586.66	1.24	0.57	2.07
Net Debt to EBITDA	-0.27	-0.95	-0.38	0.11	0.08	0.90	139.90	-0.14	-0.14	1.28
Long-Term Debt to EBITDA	0.38	0.86	1.19	0.80	0.82	-3.39	-310.07	1.24	0.57	2.07
Debt to NOPAT	1.25	-27.06	-4.16	0.48	33.27	-1.11	-3.42	53.96	1.33	5.51
Net Debt to NOPAT	-0.81	29.86	1.33	0.07	3.22	0.30	0.82	-6.15	-0.32	3.41
Long-Term Debt to NOPAT	1.15	-27.06	-4.16	0.48	33.27	-1.11	-1.81	53.96	1.33	5.51
Altman Z-Score	2.71	2.61	2.25	3.27	2.64	1.53	1.59	2.80	3.60	2.22
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.13	4.76	3.59	2.96	2.72	4.40	1.83	2.54	2.40	2.67
Quick Ratio	3.51	4.01	3.03	2.36	2.19	3.51	1.55	2.05	1.80	2.08
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	251	508	-108	571	329	487	234	-23	474	-1,054
Operating Cash Flow to CapEx	128.84%	320.64%	99.21%	132.13%	209.96%	863.65%	0.00%	111.26%	256.22%	152.60%
Free Cash Flow to Firm to Interest Expense	16.73	22.17	-5.47	23.54	13.06	19.88	9.75	-0.29	27.42	-36.22
Operating Cash Flow to Interest Expense	95.09	32.93	18.80	22.99	33.97	22.02	5.70	2.95	48.24	23.53
Operating Cash Flow Less CapEx to Interest Expense	21.29	22.66	-0.15	5.59	17.79	19.47	7.69	0.30	29.41	8.11
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.46	0.23	0.27	0.39	0.46	0.33	0.25	0.44	0.66	0.54
Accounts Receivable Turnover	5.49	3.96	4.24	4.77	5.28	5.16	5.78	5.99	6.66	6.70
Inventory Turnover	14.51	7.11	9.55	11.19	11.72	9.38	10.18	16.64	18.88	15.41
Fixed Asset Turnover	0.59	0.30	0.36	0.50	0.60	0.44	0.36	0.68	0.98	0.93
Accounts Payable Turnover	11.74	8.83	10.81	12.32	20.26	29.09	17.66	14.39	13.34	12.29
Days Sales Outstanding (DSO)	66.45	92.26	86.18	76.48	69.18	70.80	63.13	60.95	54.82	54.47
Days Inventory Outstanding (DIO)	25.15	51.34	38.20	32.61	31.15	38.91	35.87	21.93	19.34	23.68
Days Payable Outstanding (DPO)	31.09	41.34	33.75	29.63	18.02	12.55	20.67	25.37	27.36	29.69
Cash Conversion Cycle (CCC)	60.51	102.27	90.63	79.46	82.31	97.17	78.33	57.51	46.80	48.46
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	4,548	4,022	4,012	4,466	4,152	3,231	2,697	2,730	2,667	4,045
Invested Capital Turnover	0.71	0.38	0.45	0.59	0.65	0.48	0.41	0.76	1.06	0.82
Increase / (Decrease) in Invested Capital	176	-526	-10	455	-315	-921	-534	33	-63	1,377
Enterprise Value (EV)	2,900	4,329	3,823	5,576	3,441	1,208	2,372	3,485	3,876	4,107
Market Capitalization	3,248	4,872	3,980	5,507	3,395	1,337	2,617	3,547	4,005	3,004
Book Value per Share	$45.44	$42.20	$38.35	$40.23	$36.66	$30.88	$26.99	$26.27	$27.88	$29.54
Tangible Book Value per Share	$45.44	$42.15	$37.41	$38.96	$35.11	$29.70	$25.89	$25.19	$26.81	$28.53
Total Capital	5,427	5,053	4,657	4,877	4,492	3,799	3,938	3,308	3,317	4,699
Total Debt	532	492	493	494	479	481	1,025	543	545	1,782
Total Long-Term Debt	492	492	493	494	479	481	542	543	545	1,782
Net Debt	-348	-543	-157	69	46	-128	-245	-62	-130	1,102
Capital Expenditures (CapEx)	1,109	235	374	422	408	62	-48	210	325	449
Debt-free, Cash-free Net Working Capital (DFCFNWC)	355	293	325	413	304	167	69	223	178	166
Debt-free Net Working Capital (DFNWC)	1,130	1,243	891	738	705	744	1,204	608	588	745
Net Working Capital (NWC)	1,091	1,243	891	738	705	744	720	608	588	745
Net Nonoperating Expense (NNE)	6.45	39	9.85	543	48	60	26	3.10	-23	-21
Net Nonoperating Obligations (NNO)	-348	-539	-153	84	140	-87	-215	-35	-104	1,127
Total Depreciation and Amortization (D&A)	609	600	587	585	565	484	421	404	383	408
Debt-free, Cash-free Net Working Capital to Revenue	11.23%	18.03%	18.01%	16.59%	10.86%	9.41%	5.68%	10.81%	6.19%	6.02%
Debt-free Net Working Capital to Revenue	35.74%	76.50%	49.36%	29.69%	25.19%	41.95%	98.78%	29.54%	20.46%	27.03%
Net Working Capital to Revenue	34.51%	76.50%	49.36%	29.69%	25.19%	41.95%	59.11%	29.54%	20.46%	27.03%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.90	($0.54)	($1.20)	$4.39	($0.34)	($4.60)	($3.04)	$0.05	$4.18	$3.43
Adjusted Weighted Average Basic Shares Outstanding	107.75M	108.00M	108.50M	108.85M	109.22M	108.01M	107.82M	105.89M	102.45M	98.86M
Adjusted Diluted Earnings per Share	$3.87	($0.54)	($1.20)	$4.37	($0.34)	($4.60)	($3.04)	$0.05	$4.16	$3.43
Adjusted Weighted Average Diluted Shares Outstanding	108.57M	108.00M	108.50M	109.39M	109.22M	108.01M	107.82M	106.56M	102.85M	99.07M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	107.79M	108.18M	108.61M	109.04M	108.45M	107.60M	108.00M	105.39M	99.43M	98.76M
Normalized Net Operating Profit after Tax (NOPAT)	444	-21	-133	23	144	-43	-238	32	426	338
Normalized NOPAT Margin	14.05%	-1.28%	-7.36%	0.94%	5.13%	-2.40%	-19.56%	1.53%	14.82%	12.25%
Pre Tax Income Margin	20.93%	-4.47%	-10.23%	0.64%	-1.83%	-35.88%	-35.28%	1.52%	20.66%	17.45%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	44.67	-1.18	-8.65	1.32	0.75	-25.56	-17.65	0.44	33.04	15.64
NOPAT to Interest Expense	28.42	-0.79	-5.99	42.28	0.57	-17.74	-12.52	0.13	23.78	11.11
EBIT Less CapEx to Interest Expense	-29.14	-11.45	-27.60	-16.08	-15.43	-28.11	-15.65	-2.22	14.21	0.22
NOPAT Less CapEx to Interest Expense	-45.39	-11.06	-24.94	24.88	-15.61	-20.29	-10.52	-2.52	4.96	-4.31
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	70.97%	-528.18%	-238.29%	63.90%	-931.25%	-52.65%	-33.46%	1,544.59%	46.41%	48.95%
Augmented Payout Ratio	85.16%	-528.18%	-238.29%	63.90%	-1,058.36%	-58.41%	-33.46%	2,652.01%	103.36%	63.85%

This table displays calculated financial ratios and metrics derived from Helmerich & Payne's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	65.63%	83.63%	75.61%	64.51%	31.57%	4.48%	-5.90%	-10.57%	-3.62%	5.18%	0.02%
EBITDA Growth	409.48%	1,095.02%	318.85%	237.88%	81.75%	18.49%	-9.91%	-20.43%	-12.61%	4.55%	-11.63%
EBIT Growth	141.58%	177.24%	434.35%	856.08%	354.57%	52.41%	-14.80%	-36.44%	-22.71%	2.53%	-26.51%
NOPAT Growth	156.66%	170.40%	462.60%	943.69%	239.77%	34.97%	-13.26%	-39.99%	-22.63%	7.09%	-31.26%
Net Income Growth	131.95%	157.53%	289.14%	3,396.62%	436.80%	70.45%	-2.03%	-48.29%	-6.93%	-2.76%	-42.45%
EPS Growth	130.77%	157.53%	289.58%	3,200.00%	481.25%	83.33%	3.30%	-45.81%	-5.38%	0.00%	-42.55%
Operating Cash Flow Growth	215.11%	151.55%	5,085.88%	522.97%	199.50%	83.06%	-5.71%	2.02%	-32.57%	-21.39%	-9.41%
Free Cash Flow Firm Growth	-53.25%	-96.80%	-79.15%	-67.76%	-19.28%	753.53%	12.64%	23.06%	-101.37%	-1,127.02%	-1,329.50%
Invested Capital Growth	-5.72%	1.22%	0.61%	1.95%	-2.01%	-2.30%	-0.34%	-0.66%	3.07%	51.63%	48.97%
Revenue Q/Q Growth	17.67%	14.74%	13.99%	6.89%	-5.88%	-8.89%	2.66%	1.59%	1.42%	-0.56%	-2.38%
EBITDA Q/Q Growth	66.70%	25.43%	43.74%	12.42%	-10.33%	-18.23%	9.29%	-0.65%	-1.51%	-2.18%	-7.62%
EBIT Q/Q Growth	241.06%	109.52%	111.40%	21.01%	-15.20%	-29.75%	18.18%	-9.72%	3.13%	-6.81%	-15.29%
NOPAT Q/Q Growth	293.81%	55.84%	126.17%	23.50%	-21.95%	-38.09%	45.36%	-14.56%	0.63%	-14.31%	-6.68%
Net Income Q/Q Growth	456.75%	156.53%	113.32%	68.86%	-41.91%	-18.54%	22.61%	-10.87%	4.54%	-14.89%	-27.43%
EPS Q/Q Growth	420.00%	162.50%	116.67%	70.33%	-40.00%	-17.20%	22.08%	-10.64%	4.76%	-12.50%	-29.87%
Operating Cash Flow Q/Q Growth	332.23%	19.98%	58.07%	-24.00%	107.80%	-26.67%	-18.58%	-17.78%	37.34%	-14.51%	-6.16%
Free Cash Flow Firm Q/Q Growth	-20.39%	-92.46%	513.44%	-12.46%	99.30%	-20.25%	-19.05%	-4.36%	-102.22%	-59,731.12%	3.09%
Invested Capital Q/Q Growth	0.78%	-0.96%	-0.03%	2.18%	-3.14%	-1.25%	1.97%	1.85%	0.49%	45.27%	0.19%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	31.44%	34.71%	40.33%	41.46%	40.58%	37.88%	40.27%	41.44%	40.07%	41.02%	39.02%
EBITDA Margin	24.29%	26.55%	33.48%	35.21%	33.55%	30.11%	32.06%	31.33%	30.42%	29.93%	28.32%
Operating Margin	6.13%	12.16%	20.04%	22.78%	20.55%	14.21%	18.23%	16.07%	15.95%	15.36%	13.29%
EBIT Margin	5.92%	10.81%	20.05%	22.70%	20.45%	15.77%	18.15%	16.13%	16.40%	15.37%	13.34%
Profit (Net Income) Margin	3.23%	7.21%	13.50%	21.33%	13.16%	11.77%	14.06%	12.33%	12.71%	10.88%	8.09%
Tax Burden Percent	92.43%	62.41%	74.99%	76.24%	70.09%	68.87%	75.98%	72.49%	72.46%	64.87%	71.67%
Interest Burden Percent	58.96%	106.91%	89.78%	123.23%	91.82%	108.36%	101.89%	105.45%	106.94%	109.10%	84.59%
Effective Tax Rate	9.01%	37.73%	25.01%	23.76%	29.91%	31.13%	24.02%	27.51%	27.54%	35.13%	28.33%
Return on Invested Capital (ROIC)	3.48%	5.75%	13.08%	16.79%	15.01%	10.41%	14.39%	11.52%	11.47%	8.18%	7.75%
ROIC Less NNEP Spread (ROIC-NNEP)	46.67%	7.57%	40.77%	194.27%	-88.44%	-8.33%	9.48%	1,431.17%	-8.73%	9.43%	5.93%
Return on Net Nonoperating Assets (RNNOA)	-0.49%	-0.33%	-0.59%	1.21%	-0.28%	0.21%	-0.10%	0.17%	0.12%	1.70%	1.11%
Return on Equity (ROE)	2.99%	5.41%	12.50%	18.00%	14.73%	10.62%	14.29%	11.69%	11.60%	9.88%	8.86%
Cash Return on Invested Capital (CROIC)	2.72%	-0.84%	5.42%	9.61%	16.53%	17.56%	14.91%	12.99%	8.59%	-31.40%	-30.66%
Operating Return on Assets (OROA)	2.38%	4.74%	10.79%	13.93%	13.43%	10.37%	11.63%	10.09%	10.12%	8.34%	7.18%
Return on Assets (ROA)	1.30%	3.16%	7.26%	13.09%	8.64%	7.74%	9.01%	7.71%	7.84%	5.90%	4.36%
Return on Common Equity (ROCE)	2.99%	5.41%	12.50%	18.00%	14.73%	10.62%	14.29%	11.69%	11.60%	9.88%	8.86%
Return on Equity Simple (ROE_SIMPLE)	-4.31%	0.00%	5.66%	11.77%	14.85%	0.00%	15.66%	12.59%	12.12%	0.00%	10.31%
Net Operating Profit after Tax (NOPAT)	31	48	108	134	104	65	94	80	81	69	64
NOPAT Margin	5.58%	7.57%	15.03%	17.36%	14.40%	9.78%	13.85%	11.65%	11.56%	9.96%	9.52%
Net Nonoperating Expense Percent (NNEP)	-43.19%	-1.82%	-27.69%	-177.48%	103.44%	18.74%	4.91%	-1,419.65%	20.20%	-1.24%	1.82%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	2.84%	-	-	-	1.36%
Cost of Revenue to Revenue	68.56%	65.29%	59.67%	58.54%	59.42%	62.12%	59.73%	58.56%	59.93%	58.98%	60.98%
SG&A Expenses to Revenue	8.17%	7.39%	6.73%	6.87%	6.81%	8.50%	8.36%	9.02%	9.58%	8.56%	9.31%
R&D to Revenue	1.18%	1.13%	0.96%	1.13%	0.98%	1.11%	1.27%	1.88%	1.51%	1.28%	1.38%
Operating Expenses to Revenue	25.31%	22.55%	20.29%	18.68%	20.03%	23.68%	22.04%	25.36%	24.11%	25.66%	25.74%
Earnings before Interest and Taxes (EBIT)	33	68	144	175	148	104	123	111	114	107	90
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	134	168	241	271	243	199	217	216	212	208	192
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.50	1.28	1.75	1.26	1.27	1.44	1.25	1.45	1.23	1.03	1.07
Price to Tangible Book Value (P/TBV)	1.57	1.34	1.82	1.31	1.32	1.50	1.30	1.50	1.28	1.07	1.11
Price to Revenue (P/Rev)	2.32	1.72	2.03	1.30	1.21	1.39	1.22	1.48	1.29	1.09	1.15
Price to Earnings (P/E)	0.00	510.12	30.91	10.70	8.54	9.23	7.99	11.51	10.18	8.73	10.41
Dividend Yield	2.56%	2.97%	2.74%	3.01%	2.99%	2.48%	2.88%	2.24%	3.05%	4.14%	3.94%
Earnings Yield	0.00%	0.20%	3.24%	9.34%	11.71%	10.84%	12.51%	8.69%	9.82%	11.46%	9.61%
Enterprise Value to Invested Capital (EV/IC)	1.49	1.28	1.74	1.24	1.25	1.45	1.24	1.44	1.22	1.02	1.05
Enterprise Value to Revenue (EV/Rev)	2.32	1.69	2.00	1.29	1.19	1.35	1.19	1.45	1.25	1.49	1.54
Enterprise Value to EBITDA (EV/EBITDA)	14.37	7.94	7.62	4.25	3.66	4.06	3.63	4.56	4.04	4.76	5.06
Enterprise Value to EBIT (EV/EBIT)	0.00	100.79	21.34	8.23	6.31	6.79	6.14	8.20	7.54	9.03	10.04
Enterprise Value to NOPAT (EV/NOPAT)	0.00	346.59	28.85	10.83	8.54	9.43	8.50	11.64	10.71	12.70	14.43
Enterprise Value to Operating Cash Flow (EV/OCF)	25.12	14.90	11.20	6.38	4.59	4.65	4.10	4.83	4.67	6.00	6.35
Enterprise Value to Free Cash Flow (EV/FCFF)	53.14	0.00	32.10	13.01	7.49	8.18	8.30	11.05	14.47	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.19	0.19	0.61	0.60
Long-Term Debt to Equity	0.20	0.20	0.20	0.20	0.20	0.20	0.20	0.19	0.19	0.61	0.60
Financial Leverage	-0.01	-0.04	-0.01	0.01	0.00	-0.03	-0.01	0.00	-0.01	0.18	0.19
Leverage Ratio	1.54	1.65	1.59	1.58	1.59	1.58	1.60	1.58	1.59	1.79	1.79
Compound Leverage Factor	0.91	1.77	1.43	1.95	1.46	1.71	1.64	1.67	1.70	1.95	1.52
Debt to Total Capital	16.56%	16.40%	16.51%	16.45%	16.75%	16.43%	16.50%	16.29%	16.04%	37.92%	37.68%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	16.56%	16.40%	16.51%	16.45%	16.75%	16.43%	16.50%	16.29%	16.04%	37.92%	37.68%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	83.44%	83.60%	83.49%	83.55%	83.25%	83.57%	83.50%	83.71%	83.96%	62.08%	62.32%
Debt to EBITDA	1.90	1.24	0.87	0.67	0.59	0.57	0.59	0.62	0.65	2.07	2.13
Net Debt to EBITDA	-0.02	-0.14	-0.11	-0.02	-0.06	-0.14	-0.09	-0.09	-0.14	1.28	1.29
Long-Term Debt to EBITDA	1.90	1.24	0.87	0.67	0.59	0.57	0.59	0.62	0.65	2.07	2.13
Debt to NOPAT	-6.03	53.96	3.31	1.70	1.38	1.33	1.37	1.59	1.71	5.51	6.06
Net Debt to NOPAT	0.05	-6.15	-0.41	-0.05	-0.14	-0.32	-0.21	-0.22	-0.36	3.41	3.67
Long-Term Debt to NOPAT	-6.03	53.96	3.31	1.70	1.38	1.33	1.37	1.59	1.71	5.51	6.06
Altman Z-Score	2.93	2.83	3.33	3.04	3.04	3.25	2.99	3.23	3.01	2.02	2.05
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.36	2.54	2.30	2.43	2.29	2.40	2.11	2.16	2.12	2.67	2.81
Quick Ratio	1.82	2.05	1.83	1.86	1.71	1.80	1.57	1.62	1.54	2.08	2.19
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	198	15	92	80	160	127	103	99	-2.19	-1,308	-1,268
Operating Cash Flow to CapEx	155.55%	174.23%	284.98%	205.03%	344.48%	201.33%	140.42%	131.45%	164.31%	178.18%	167.81%
Free Cash Flow to Firm to Interest Expense	45.25	3.45	21.02	18.90	36.93	29.18	23.58	23.14	-0.50	-81.12	-56.85
Operating Cash Flow to Interest Expense	22.36	27.10	42.57	33.23	67.70	49.18	39.98	33.73	45.52	10.47	7.10
Operating Cash Flow Less CapEx to Interest Expense	7.98	11.55	27.63	17.02	48.05	24.75	11.51	8.07	17.82	4.59	2.87
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.40	0.44	0.54	0.61	0.66	0.66	0.64	0.63	0.62	0.54	0.54
Accounts Receivable Turnover	5.61	5.99	5.96	6.25	6.71	6.66	5.97	5.74	6.29	6.70	6.39
Inventory Turnover	14.59	16.64	17.52	18.24	18.38	18.88	17.64	15.94	15.10	15.41	14.37
Fixed Asset Turnover	0.57	0.68	0.79	0.90	0.96	0.98	0.96	0.93	0.92	0.93	0.92
Accounts Payable Turnover	13.99	14.39	12.24	12.59	12.68	13.34	11.18	10.35	10.53	12.29	10.74
Days Sales Outstanding (DSO)	65.06	60.95	61.25	58.44	54.38	54.82	61.17	63.56	57.99	54.47	57.11
Days Inventory Outstanding (DIO)	25.02	21.93	20.83	20.01	19.86	19.34	20.70	22.89	24.18	23.68	25.40
Days Payable Outstanding (DPO)	26.09	25.37	29.81	29.00	28.79	27.36	32.64	35.28	34.66	29.69	33.99
Cash Conversion Cycle (CCC)	63.99	57.51	52.27	49.45	45.45	46.80	49.22	51.18	47.50	48.46	48.52
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,757	2,730	2,729	2,789	2,701	2,667	2,720	2,771	2,784	4,045	4,052
Invested Capital Turnover	0.62	0.76	0.87	0.97	1.04	1.06	1.04	0.99	0.99	0.82	0.81
Increase / (Decrease) in Invested Capital	-167	33	17	53	-55	-63	-9.28	-18	83	1,377	1,332
Enterprise Value (EV)	4,102	3,485	4,737	3,455	3,378	3,876	3,373	3,987	3,410	4,107	4,242
Market Capitalization	4,106	3,547	4,805	3,472	3,434	4,005	3,455	4,062	3,525	3,004	3,162
Book Value per Share	$25.95	$26.27	$26.05	$26.37	$26.40	$27.88	$27.76	$28.36	$28.94	$29.54	$29.84
Tangible Book Value per Share	$24.87	$25.19	$24.99	$25.33	$25.35	$26.81	$26.70	$27.32	$27.91	$28.53	$28.84
Total Capital	3,275	3,308	3,288	3,299	3,253	3,317	3,305	3,349	3,402	4,699	4,728
Total Debt	542	543	543	543	545	545	545	545	546	1,782	1,782
Total Long-Term Debt	542	543	543	543	545	545	545	545	546	1,782	1,782
Net Debt	-4.66	-62	-68	-17	-56	-130	-82	-75	-115	1,102	1,080
Capital Expenditures (CapEx)	63	67	65	69	85	107	124	109	120	95	94
Debt-free, Cash-free Net Working Capital (DFCFNWC)	212	223	219	293	205	178	156	164	145	166	189
Debt-free Net Working Capital (DFNWC)	545	608	609	591	559	588	520	510	514	745	789
Net Working Capital (NWC)	545	608	609	591	559	588	520	510	514	745	789
Net Nonoperating Expense (NNE)	13	2.28	11	-30	8.96	-13	-1.36	-4.68	-8.03	-6.36	9.72
Net Nonoperating Obligations (NNO)	24	-35	-16	33	-6.77	-104	-40	-33	-73	1,127	1,105
Total Depreciation and Amortization (D&A)	101	99	97	96	95	95	94	105	98	101	101
Debt-free, Cash-free Net Working Capital to Revenue	11.96%	10.81%	9.24%	10.96%	7.20%	6.19%	5.52%	5.98%	5.34%	6.02%	6.87%
Debt-free Net Working Capital to Revenue	30.76%	29.54%	25.71%	22.12%	19.67%	20.46%	18.36%	18.55%	18.86%	27.03%	28.62%
Net Working Capital to Revenue	30.76%	29.54%	25.71%	22.12%	19.67%	20.46%	18.36%	18.55%	18.86%	27.03%	28.62%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.16	$0.42	$0.92	$1.55	$0.93	$0.78	$0.95	$0.85	$0.89	$0.74	$0.55
Adjusted Weighted Average Basic Shares Outstanding	105.29M	105.89M	105.25M	103.97M	101.16M	102.45M	99.14M	98.77M	98.75M	98.86M	98.87M
Adjusted Diluted Earnings per Share	$0.16	$0.42	$0.91	$1.55	$0.93	$0.77	$0.94	$0.84	$0.88	$0.77	$0.54
Adjusted Weighted Average Diluted Shares Outstanding	106.02M	106.56M	106.10M	104.36M	101.55M	102.85M	99.63M	99.05M	99.01M	99.07M	99.16M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	105.29M	105.39M	104.49M	102.58M	99.43M	99.43M	98.83M	98.72M	98.76M	98.76M	99.38M
Normalized Net Operating Profit after Tax (NOPAT)	28	46	115	132	107	70	92	82	83	71	73
Normalized NOPAT Margin	5.07%	7.31%	16.04%	17.11%	14.84%	10.66%	13.58%	11.91%	11.84%	10.19%	10.81%
Pre Tax Income Margin	3.49%	11.56%	18.00%	27.97%	18.78%	17.09%	18.50%	17.01%	17.54%	16.77%	11.28%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	7.45	15.77	33.13	41.19	34.24	23.83	28.12	26.04	26.39	6.61	4.05
NOPAT to Interest Expense	7.02	11.05	24.83	31.51	24.11	14.79	21.46	18.81	18.60	4.29	2.89
EBIT Less CapEx to Interest Expense	-6.92	0.22	18.19	24.98	14.59	-0.60	-0.36	0.39	-1.31	0.74	-0.18
NOPAT Less CapEx to Interest Expense	-7.35	-4.50	9.90	15.30	4.46	-9.64	-7.01	-6.85	-9.10	-1.59	-1.34
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-91.74%	1,544.59%	84.81%	48.18%	44.59%	46.41%	44.43%	51.82%	50.62%	48.95%	49.77%
Augmented Payout Ratio	-157.13%	2,652.01%	120.64%	92.87%	106.09%	103.36%	103.56%	95.32%	65.43%	63.85%	51.07%

Frequently Asked Questions About Helmerich & Payne's Financials

When does Helmerich & Payne's fiscal year end?

According to the most recent income statement we have on file, Helmerich & Payne's financial year ends in September. Their financial year 2024 ended on September 30, 2024.

How has Helmerich & Payne's net income changed over the last 9 years?

Helmerich & Payne's net income appears to be on an upward trend, with a most recent value of $344.17 million in 2024, falling from $420.43 million in 2015. The previous period was $434.10 million in 2023.

What is Helmerich & Payne's operating income?

Helmerich & Payne's total operating income in 2024 was $451.90 million, based on the following breakdown:

Total Gross Profit: $1.12 billion
Total Operating Expenses: $670 million

How has Helmerich & Payne revenue changed over the last 9 years?

Over the last 9 years, Helmerich & Payne's total revenue changed from $3.16 billion in 2015 to $2.76 billion in 2024, a change of -12.8%.

How much debt does Helmerich & Payne have?

Helmerich & Payne's total liabilities were at $2.86 billion at the end of 2024, a 77.9% increase from 2023, and a 27.2% increase since 2015.

How much cash does Helmerich & Payne have?

In the past 9 years, Helmerich & Payne's cash and equivalents has ranged from $217.34 million in 2024 to $917.53 million in 2021, and is currently $217.34 million as of their latest financial filing in 2024.

How has Helmerich & Payne's book value per share changed over the last 9 years?

Over the last 9 years, Helmerich & Payne's book value per share changed from 45.44 in 2015 to 29.54 in 2024, a change of -35.0%.

Remove Ads

Related Companies

This page (NYSE:HP) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Helmerich & Payne (HP) Financials

Frequently Asked Questions About Helmerich & Payne's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Helmerich & Payne (HP) Financials

Annual Income Statements for Helmerich & Payne

Quarterly Income Statements for Helmerich & Payne

Annual Cash Flow Statements for Helmerich & Payne

Quarterly Cash Flow Statements for Helmerich & Payne

Annual Balance Sheets for Helmerich & Payne

Quarterly Balance Sheets for Helmerich & Payne

Annual Metrics and Ratios for Helmerich & Payne

Quarterly Metrics and Ratios for Helmerich & Payne

Frequently Asked Questions About Helmerich & Payne's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools